Tobacco smoking and all-cause mortality in a large Australian cohort study: findings from a mature epidemic with current low smoking prevalence.
- Authors
- Banks, Emily; Joshy, Grace; Weber, Marianne F; Liu, Bette; Grenfell, Robert; Egger, Sam; Paige, Ellie; Lopez, Alan D; Sitas, Freddy; Beral, Valerie
- Year
- 2015
- Journal
- BMC medicine
- PMID
- 25857449
- DOI
- 10.1186/s12916-015-0281-z
- PMCID
- PMC4339244
BACKGROUND: The smoking epidemic in Australia is characterised by historic levels of prolonged smoking, heavy smoking, very high levels of long-term cessation, and low current smoking prevalence, with 13% of adults reporting that they smoked daily in 2013. Large-scale quantitative evidence on the relationship of tobacco smoking to mortality in Australia is not available despite the potential to provide independent international evidence about the contemporary risks of smoking. METHODS: This is a prospective study of 204,953 individuals aged β₯45Β years sampled from the general population of New South Wales, Australia, who joined the 45 and Up Study from 2006-2009, with linked questionnaire, hospitalisation, and mortality data to mid-2012 and with no history of cancer (other than melanoma and non-melanoma skin cancer), heart disease, stroke, or thrombosis. Hazard ratios (described here as relative risks, RRs) for all-cause mortality among current and past smokers compared to never-smokers were estimated, adjusting for age, education, income, region of residence, alcohol, and body mass index. RESULTS: Overall, 5,593 deaths accrued during follow-up (874,120 person-years; mean: 4.26Β years); 7.7% of participants were current smokers and 34.1% past smokers at baseline. Compared to never-smokers, the adjusted RR (95% CI) of mortality was 2.96 (2.69-3.25) in current smokers and was similar in men (2.82 (2.49-3.19)) and women (3.08 (2.63-3.60)) and according to birth cohort. Mortality RRs increased with increasing smoking intensity, with around two- and four-fold increases in mortality in current smokers of β€14 (mean 10/day) and β₯25 cigarettes/day, respectively, compared to never-smokers. Among past smokers, mortality diminished gradually with increasing time since cessation and did not differ significantly from never-smokers in those quitting prior to age 45. Current smokers are estimated to die an average of 10Β years earlier than non-smokers. CONCLUSIONS: In Australia, up to two-thirds of deaths in current smokers can be attributed to smoking. Cessation reduces mortality compared with continuing to smoke, with cessation earlier in life resulting in greater reductions.
Prevalence of current tobacco smoking among Australian adults, 1945β2013. Data are from Scollo MM and Winstanley MH (1945β2010) [9], the Australian Health Survey (2011β2012) [10], and the National Drug Strategy Household Survey (2013) [8]. *Prior to 2001, the prevalences indicate those describing themselves as βcurrent smokersβ; from 2001β2010 the prevalences indicate those smoking daily or at least weekly. In 2011/2012 and 2013, they relate to current smoking, including daily, weekly, or less than weekly smoking. Data prior to 1980 are considered less reliable than from subsequent years and are represented with a dotted line [9].
Relative risks and absolute rates of all-cause mortality in the 45 and Up Study in current and past smokers relative to never-smokers, overall and by decade of birth. Rate/1,000 person-years, indirectly standardised for age using the whole cohort distribution. *RR adjusted for age only (underlying time variable). #RR adjusted for age, region of residence (major cities, inner regional areas, remote areas), alcohol consumption (0, 1β14, β₯15 drinks/week), annual pre-tax household income (AUD <$20,000, $20,000-$39,999, $40,000-$69,999, β₯$70,000), education (<secondary school, secondary school graduation, certificate or diploma, university graduate), and BMI (<20, 20β24.9, 25β29.9, β₯30). RRs are plotted on a log-scale and are represented with squares with areas inversely proportional to the variance of the logarithm of the RR, providing an indication of the amount of statistical information available; 95% CIs are indicated by horizontal lines.
Age standardised rates of all-cause mortality in current smokers and never-smokers, by smoking intensity. Categories of smoking intensity (0 (never smokers), β€14, 15β24, β₯25 cigarettes/day) are based on smoking behaviour reported at baseline. Rates are plotted against the mean number of cigarettes within each pre-defined category, based on smoking intensity reported at the 3-year resurvey among current smokers at resurvey, to minimise regression dilution bias. Vertical lines represent 95% confidence intervals; the intervals around the rates for never-smokers are small and contained within the squares that indicate the rates [Men 6.8 (6.4β7.2), Women 4.0 (3.8β4.2)].
Relative risk of all-cause mortality in past smokers relative to never-smokers in the 45 and Up Study, by age at smoking cessation. RRs adjusted for age, sex, region of residence (major cities, inner regional areas, remote areas), alcohol consumption (0, 1β14, β₯15 drinks/week), annual pre-tax household income (AUD <$20,000, $20,000β$39,999, $40,000β$69,999, β₯$70,000), education (<secondary school, secondary school graduation, certificate or diploma, university graduate), and BMI (<20, 20β24.9, 25β29.9, β₯30). RRs plotted on log-scale against median value for age at stopping smoking categories <25, 25β34, 35β44, and 45β54 years.
No entities extracted from this document yet.
No uploaded files.
In this knowledge base
| Title | Year | PMID |
|---|---|---|
| A protocadherin gene cluster regulatory variant is associated with nicotine withdrawal and the urge to smoke. | 2017 | 27067016 |
External
| Title | Authors | Journal | Year | Link |
|---|---|---|---|---|
| Effects of a Modified Exposure Claim for an e-Cigarette on Claim Comprehension, Behavioral Intentions, and Risk Perceptions Among US Adult Tobacco Users and Nonusers: Randomized Experimental Study. | Magnani P et al. | β | 2026 | β |
| Is the provision of a national opt-out tobacco dependence treatment service in acute hospitals in England equitable? A national cohort study. | Agrawal S et al. | β | 2026 | β |
| Mortality and morbidity burden associated with smoking: evidence from a 1.6 million cohort in Hong Kong. | Wang B et al. | β | 2026 | β |
| Protecting children from second-hand tobacco smoke in the home: the need for a new approach. | Semple S et al. | β | 2026 | β |
| Canadian Cardiovascular Society Clinical Practice Update on Contemporary Approaches to Smoking Cessation. | Mir H et al. | β | 2025 | β |
| Characteristics of nicotine product use, perceptions of dependence, and passive exposure among first-year university students in Brazil. | Silva MM et al. | β | 2025 | β |
| Comprehensive analysis of smoking as a risk factor and its prognostic implications in patients with deep neck infections. | Tseng YC et al. | β | 2025 | β |
| Cumulative smoking exposure impacts oncologic outcomes of upper tract urothelial carcinoma. | Bhanvadia R et al. | β | 2025 | β |
| Develop a personalised serious game applet for smoking cessation: protocol for enterprise-based cluster randomised controlled trial. | Kong X et al. | β | 2025 | β |
| Engagement of Indigenous peoples in commercial tobacco reform strategies: a scoping review protocol. | Perusco AD et al. | β | 2025 | β |
| Estimating cardiovascular mortality in patients with hypertension using machine learning: The role of depression classification based on lifestyle and physical activity. | Liu X et al. | β | 2025 | β |
| Estimating Young Adult Uptake of Smoking by Area Across the United Kingdom. | Jackson SE et al. | β | 2025 | β |
| Experiences of Tobacco Smoking and Quitting Among Mental Health Consumers. | Roennfeldt H et al. | β | 2025 | β |
| Extracellular vesicle-encapsulated microRNA signatures of cigarette smoking and smoking-related harm. | Eckhardt CM et al. | β | 2025 | β |
| Healthy lifestyle, multimorbidity and all-cause mortality among older people: a retrospective cohort study based on CLHLS 2005-2018. | Tang S et al. | β | 2025 | β |
| Looking back and planning ahead: the tobacco endgame and controlling tobacco industry interference in Aotearoa New Zealand. | Hoek J et al. | β | 2025 | β |
| Random forest algorithm for predicting tobacco use and identifying determinants among pregnant women in 26 sub-Saharan African countries: a 2024 analysis. | Taye EA et al. | β | 2025 | β |
| Relationship of tobacco smoking to cause-specific mortality: contemporary estimates from Australia. | Joshy G et al. | β | 2025 | β |
| Risk of all-cause mortality by various cigarette smoking indices: A longitudinal study using the Korea National Health Examination Baseline Cohort in South Korea. | Kang H et al. | β | 2025 | β |
| Smoking's pop culture revival is an unwelcome throwback for public health. | Cerny C | β | 2025 | β |
| The impact of drinking on smoking cessation outcomes among Hong Kong Chinese youth smokers. | Ho KY et al. | β | 2025 | β |
| The relationship between nicotine dependence and willingness to quit smoking: A cross-sectional study. | Murriky A et al. | β | 2025 | β |
| Tobacco control in TΓΌrkiye: A brief review of achievements, challenges, and prospects. | SΓΆnmez ΓF | β | 2025 | β |
| Using Bayesian evidence synthesis to quantify uncertainty in population trends in smoking behaviour. | Wade S et al. | β | 2025 | β |
| 18-Ξ²-glycyrrhetinic acid-loaded polymeric nanoparticles attenuate cigarette smoke-induced markers of impaired antiviral response in vitro. | De Rubis G et al. | β | 2024 | β |
| Cost-Effectiveness of a Comprehensive Primary Care Smoking Treatment Program. | Mundt MP et al. | β | 2024 | β |
| Countering Tobacco Industry Interference: A Policy Brief on Strengthening the WHO FCTC Article 5.3 Adoption in India. | Goel S et al. | β | 2024 | β |
| Estimated impact of a tobacco-elimination strategy on lung-cancer mortality in 185 countries: a population-based birth-cohort simulation study. | Rey Brandariz J et al. | β | 2024 | β |
| Fifty-year forecasts of daily smoking prevalence: can Australia reach 5% by 2030? | Wade S et al. | β | 2024 | β |
| How do New Zealand youth perceive the smoke-free generation policy? A qualitative analysis. | Hoek J et al. | β | 2024 | β |
| Impact of Smoking Reduction Scenarios on the Burden of Myocardial Infarction in the French Population Until 2035. | Kuhn J et al. | β | 2024 | β |
| Joint Associations of Diet and Device-Measured Physical Activity with Mortality and Incident CVD and Cancer: A Prospective Analysis of the UK Biobank Study. | Inan-Eroglu E et al. | β | 2024 | β |
| Lung Disease and Social Justice: Chronic Obstructive Pulmonary Disease as a Manifestation of Structural Violence. | Williams PJ et al. | β | 2024 | β |
| Patterns and perceptions of vaping among adults living in social housing: a representative survey in Great Britain, 2023. | Jackson SE et al. | β | 2024 | β |
| Protecting BMJ journals' content from tobacco industry influence. | Macdonald H et al. | β | 2024 | β |
| Reply to Pacheco Gallego and Farber, to Young <i>etΒ al.</i>, and to Aslan. | Hopkinson NS | β | 2024 | β |
| Smartphone application versus written material for smoking reduction and cessation in individuals undergoing low-dose computed tomography (LDCT) screening for lung cancer: a phase II open-label randomised controlled trial. | Iivanainen S et al. | β | 2024 | β |
| Smoking and lung cancer-70 long years on. | Hopkinson NS | β | 2024 | β |
| Targeted lung cancer screening in the age of immunotherapies and targeted therapies - an economic evaluation for Australia. | Roseleur J et al. | β | 2024 | β |
| The Effect of Incarceration on Mortality. | Norris S et al. | β | 2024 | β |
| Trend estimation of sub-national level daily smoking prevalence by age and sex in Australia. | Das S et al. | β | 2024 | β |
| Trends in non-daily cigarette smoking in England, 2006-2024. | Jackson SE et al. | β | 2024 | β |
| Trends in smoking initiation and cessation over a century in two Australian cohorts. | James AL et al. | β | 2024 | β |
| Up in smoke. The unravelling of world-leading policy changes in Smokefree legislation in Aotearoa New Zealand. | Campbell M et al. | β | 2024 | β |
| Waterpipe tobacco smoking and risk of all-cause mortality: a prospective cohort study. | Le PH et al. | β | 2024 | β |
| A critique of the Australian National Health and Medical Research Council CEO statement on electronic cigarettes. | Mendelsohn CP et al. | β | 2023 | β |
| An analysis of key stakeholder policy perspectives in the proposed e-cigarette regulations in New Zealand. | Hardie L et al. | β | 2023 | β |
| Association of a healthy lifestyle with mortality in older people. | Robb C et al. | β | 2023 | β |
| Association of the age at smoking initiation and cessation on all-cause and cause-specific mortality: The Japan Collaborative Cohort Study. | Zuhal SH et al. | β | 2023 | β |
| Associations between smokers' knowledge of causes of smoking harm and related beliefs and behaviors: Findings from the International Tobacco Control (ITC) Four Country Smoking and Vaping Survey. | King B et al. | β | 2023 | β |
| Centrilobular Emphysema Is Associated with Pectoralis Muscle Reduction in Current Smokers without Airflow Limitation. | Maetani T et al. | β | 2023 | β |
| E-Cigarettes as a Smoking Cessation Aid - Toward Common Ground and a Rational Approach. | Hopkinson NS | β | 2023 | β |
| Electronic cigarettes and health outcomes: epidemiological and public health challenges. | Banks E et al. | β | 2023 | β |
| Price elasticity of demand for cigarettes among youths in high-income countries: a systematic review. | Kjeld SG et al. | β | 2023 | β |
| Realizing the Tobacco Endgame: Understanding and mobilizing public support for banning combustible cigarette sales in the United States. | Avishai A et al. | β | 2023 | β |
| Risky health behaviors and subsequent late mortality after blood or marrow transplantation: a BMTSS report. | Balas N et al. | β | 2023 | β |
| The emergence of e-cigarette retail shops in a regulated tobacco control environment. | Scott L et al. | β | 2023 | β |
| Tobacco smoke and all-cause mortality and premature death in China: a cohort study. | Zhang L et al. | β | 2023 | β |
| Treatment vs Prevention of Head and Neck Cancer: Are We Doing Our Best for Patients? | Haugen T et al. | β | 2023 | β |
| Trends in daily cigarette consumption among smokers: a population study in England, 2008-2023 | Jackson SE et al. | β | 2023 | β |
| A comprehensive economic assessment of the health effects of tobacco use and implications for tobacco control in Bangladesh. | Nargis N et al. | β | 2022 | β |
| [Adaptation and validation of an instrument to evaluate the competence on a Brief Tobacco Intervention. BTI-ProfΒ©]. | Ramos-Morcillo AJ et al. | β | 2022 | β |
| Assessment of association between smoking and all-cause mortality among Malaysian adult population: Findings from a retrospective cohort study. | Lim KH et al. | β | 2022 | β |
| Association Between Smoking, Smoking Cessation, and Mortality by Race, Ethnicity, and Sex Among US Adults. | Thomson B et al. | β | 2022 | β |
| Capacity of the 45 and Up Study to mobilise evidence-based improvements in cancer control: lung cancer case study. | Weber MF et al. | β | 2022 | β |
| Challenges and opportunities for tobacco control in Australia: a qualitative study. | Jongenelis MI | β | 2022 | β |
| Effect of Fasting on Smoking Addiction: A Multicentered Primary Care Research. | Γnal M et al. | β | 2022 | β |
| Effect of smoking reduction, cessation, and resumption on cancer risk: A nationwide cohort study. | Yoo JE et al. | β | 2022 | β |
| Evolution of the global smoking epidemic over the past half century: strengthening the evidence base for policy action. | Dai X et al. | β | 2022 | β |
| Framework for the public health assessment of electronic cigarettes. | Banks E et al. | β | 2022 | β |
| Identifying tobacco retailers in the absence of a licensing system: lessons from Australia. | Baker J et al. | β | 2022 | β |
| Predicting risk of lung function impairment and all-cause mortality using a DNA methylation-based classifier of tobacco smoke exposure. | Eckhardt CM et al. | β | 2022 | β |
| Projections of smoking-related cancer mortality in Australia to 2044. | Luo Q et al. | β | 2022 | β |
| Real-world effectiveness of smoking cessation aids: A population survey in England with 12-month follow-up, 2015-2020. | Jackson SE et al. | β | 2022 | β |
| Smoking behaviour and passive smoke exposure of adults - Results from GEDA 2019/2020-EHIS. | Starker A et al. | β | 2022 | β |
| The 45 and Up Study: an investment in healthy ageing. | Byles J | β | 2022 | β |
| The 45 and Up Study: reflecting on contributions to global evidence using case studies on cardiovascular disease and smoking. | Paige E et al. | β | 2022 | β |
| The Association between Smoking and Mortality in Women with Breast Cancer: A Real-World Database Analysis. | Lai YC et al. | β | 2022 | β |
| Tobacco and nicotine use. | Le Foll B et al. | β | 2022 | β |
| Tobacco mythbusting-tobacco is not a major driver of foot traffic in low socio-economic small retail stores. | Wood L et al. | β | 2022 | β |
| Age as a predictor of quit attempts and quit success in smoking cessation: findings from the International Tobacco Control Four-Country survey (2002-14). | Arancini L et al. | β | 2021 | β |
| An approach to quantifying the potential importance of residual confounding in systematic reviews of observational studies: A GRADE concept paper. | Verbeek JH et al. | β | 2021 | β |
| Association Between Initiation, Intensity, and Cessation of Smoking and Mortality Risk in Patients With Cardiovascular Disease: A Cohort Study. | Wang JL et al. | β | 2021 | β |
| Association of Smoking and Smoking Cessation With Overall and Cause-Specific Mortality. | Zhu D et al. | β | 2021 | β |
| Association of smoking reduction and mortality: protocol for a systematic review and meta-analysis of longitudinal observational studies. | Aubin HJ et al. | β | 2021 | β |
| Cigarette smoking and all-cause mortality in rural Chinese male adults: 15-year follow-up of the Anqing cohort study. | Ye L et al. | β | 2021 | β |
| Long-term weight loss success and the health behaviours of adults in the USA: findings from a nationally representative cross-sectional study. | Shuval K et al. | β | 2021 | β |
| Low-intensity daily smoking and cause-specific mortality in Mexico: prospective study of 150Β 000 adults. | Thomson B et al. | β | 2021 | β |
| Nicotine Dependence in Patients with Major Depressive Disorder and Psychotic Disorders and Its Relationship with Quality of Life. | Wang P et al. | β | 2021 | β |
| Patterns and Prevalence of Daily Tobacco Smoking in Australia by Industry and Occupation: 2007-2016. | McEntee A et al. | β | 2021 | β |
| Smoking behaviours and other substance use among Indigenous and non-Indigenous Australian secondary students, 2017. | Heris C et al. | β | 2021 | β |
| There's no smoke without fire: Smoking in smoke-free acute mental health wards. | Jenkin G et al. | β | 2021 | β |
| Tobacco smoking and mortality among Aboriginal and Torres Strait Islander adults in Australia. | Thurber KA et al. | β | 2021 | β |
| Air pollution is not 'the new smoking': comparing the disease burden of air pollution and smoking across the globe, 1990-2017. | Gao W et al. | β | 2020 | β |
| An argument for phasing out sales of cigarettes. | Smith EA et al. | β | 2020 | β |
| Are smoking intensity and cessation related to cataract surgical risk in diabetic patients? Findings from the 45 and Up Study. | Han X et al. | β | 2020 | β |
| Avoidable Mortality Attributable to Anthropogenic Fine Particulate Matter (PM<sub>2.5</sub>) in Australia. | Hanigan IC et al. | β | 2020 | β |
| Close Association between Subclinical Atherosclerosis and Pulmonary Function in Middle-Aged Male Smokers. | Sugiura T et al. | β | 2020 | β |
| Electronic cigarettes: A position statement from the Thoracic Society of Australia and New Zealand. | McDonald CF et al. | β | 2020 | β |
| Evaluating an Aboriginal tobacco social marketing project in Sydney, Australia. | Poder N et al. | β | 2020 | β |
| Flavor Capsule Variants' Performance in a "Dark Market": Implications for Standardized Packaging. | Haggart K et al. | β | 2020 | β |
| Hypoxia-inducible factor and bacterial infections in chronic obstructive pulmonary disease. | Shukla SD et al. | β | 2020 | β |
| Incorporating competing risk theory into evaluations of changes in cancer survival: making the most of cause of death and routinely linked sociodemographic data. | Wright CM et al. | β | 2020 | β |
| Increased Morbidity and Mortality in Hypertensive Patients With Substance Use Disorders: Electronic Health Record Findings. | Winhusen T et al. | β | 2020 | β |
| Prevalence and correlates of food insecurity in community-based individuals with severe mental illness receiving long-acting injectable antipsychotic treatment. | Teasdale SB et al. | β | 2020 | β |
| Smoking and Mental Illness: Prevalence, Patterns and Correlates of Smoking and Smoking Cessation among Psychiatric Patients. | Asharani PV et al. | β | 2020 | β |
| Smoking history: relationships with inflammatory markers, metabolic markers, body composition, muscle strength, and cardiopulmonary capacity in current smokers. | Gouveia TDS et al. | β | 2020 | β |
| The hazards of smoking and the benefits of cessation: a critical summation of the epidemiological evidence in high-income countries. | Jha P | β | 2020 | β |
| Tobacco smoking and risk of all-cause mortality in Indonesia. | Holipah H et al. | β | 2020 | β |
| A descriptive study of a Smoke-free Teens Programme to promote smoke-free culture in schools and the community in Hong Kong. | Chung OK et al. | β | 2019 | β |
| Blood Biochemistry Analysis to Detect Smoking Status and Quantify Accelerated Aging in Smokers. | Mamoshina P et al. | β | 2019 | β |
| Cancer risk among young men with weight gain after smoking cessation: A population-based cohort study. | Kim K et al. | β | 2019 | β |
| Cessation of Cigarette Smoking and the Impact on Cancer Incidence in Human Immunodeficiency Virus-infected Persons: The Data Collection on Adverse Events of Anti-HIV Drugs Study. | Shepherd L et al. | β | 2019 | β |
| Productivity burden of smoking in Australia: a life table modelling study. | Owen AJ et al. | β | 2019 | β |
| Real-time video counselling for smoking cessation. | Tzelepis F et al. | β | 2019 | β |
| Sociodemographic, lifestyle and metabolic predictors of all-cause mortality in a cohort of community-dwelling population: an 18-year follow-up of the North West Adelaide Health Study. | Melaku YA et al. | β | 2019 | β |
| The effect of smoking intensity on all-cause and cause-specific mortality-a Mendelian randomization analysis. | Vie GΓ et al. | β | 2019 | β |
| The public health consequences of e-cigarettes: a review by the National Academies of Sciences. A call for more research, a need for regulatory action. | Prochaska JJ | β | 2019 | β |
| Tobacco Smoking and Mortality in Asia: A Pooled Meta-analysis. | Yang JJ et al. | β | 2019 | β |
| Tobacco smoking and risk of 36 cardiovascular disease subtypes: fatal and non-fatal outcomes in a large prospective Australian study. | Banks E et al. | β | 2019 | β |
| Understandings of the component causes of harm from cigarette smoking in Australia. | King B et al. | β | 2019 | β |
| Adapting, Pilot Testing and Evaluating the Kick.it App to Support Smoking Cessation for Smokers with Severe Mental Illness: A Study Protocol. | Lawn S et al. | β | 2018 | β |
| Cigarette brand loyalty among smokers in six European countries: Findings from the EUREST-PLUS ITC Europe Surveys. | Nogueira SO et al. | β | 2018 | β |
| Epigenetic prediction of complex traits and death. | McCartney DL et al. | β | 2018 | β |
| High relative risk of all-cause mortality attributed to smoking in China: Guangzhou Biobank Cohort Study. | Lam TH et al. | β | 2018 | β |
| Industry interests in gambling research: Lessons learned from other forms of hazardous consumption. | Cowlishaw S et al. | β | 2018 | β |
| Modelling the implications of reducing smoking prevalence: the public health and economic benefits of achieving a 'tobacco-free' UK. | Hunt D et al. | β | 2018 | β |
| Surveillance for Cancers Associated with Tobacco Use - United States, 2010-2014. | Gallaway MS et al. | β | 2018 | β |
| The Mutual Impact of Smoking and Low Cholesterol on All-Cause, Non-Cardiovascular, and Cardiovascular Mortalities in Males. | Parsa N et al. | β | 2018 | β |
| An Evaluation of the Youth Quitline Service Young HongΒ KongΒ Smokers. | Li WHC et al. | β | 2017 | β |
| A protocadherin gene cluster regulatory variant is associated with nicotine withdrawal and the urge to smoke. | Jensen KP et al. | β | 2017 | β |
| Body mass index and mortality in patients with type 2 diabetes mellitus: A prospective cohort study of 11,449 participants. | Liu H et al. | β | 2017 | β |
| Challenging how tobacco is sold in Australia. | Freeman B | β | 2017 | β |
| Changing smoking-mortality association over time and across social groups: National census-mortality cohort studies from 1981 to 2011. | Teng A et al. | β | 2017 | β |
| Deadly progress: changes in Australian Aboriginal and Torres Strait Islander adult daily smoking, 2004-2015. | Lovett R et al. | β | 2017 | β |
| Factors influencing the tobacco control policy process in Egypt and Iran: a scoping review. | Banks C et al. | β | 2017 | β |
| Identifying high risk individuals for targeted lung cancer screening: Independent validation of the PLCO<sub>m2012</sub> risk prediction tool. | Weber M et al. | β | 2017 | β |
| Legal does not mean unaccountable: suing tobacco companies to recover health care costs. | MacKenzie R et al. | β | 2017 | β |
| Lifestyle behaviours of Lebanese-Australians: Cross-sectional findings from The 45 and Up Study. | El Masri A et al. | β | 2017 | β |
| Long-term effectiveness of the preoperative smoking cessation programme at Western Health. | Taylor H et al. | β | 2017 | β |
| Partnering and parenting transitions associate with changing smoking status: a cohort study in young Australians. | Tian J et al. | β | 2017 | β |
| Perceptions of Menthol Cigarettes Among Twitter Users: Content and Sentiment Analysis. | Rose SW et al. | β | 2017 | β |
| Public perceptions of the tobacco-free generation in Tasmania: adults and adolescents. | Trainer E et al. | β | 2017 | β |
| Pulmonary and right ventricular dysfunction are frequently present in heart failure irrespective of left ventricular ejection fraction. | Robaeys W et al. | β | 2017 | β |
| Survival Bias When Assessing Risk Factors for Age-Related Macular Degeneration: A Tutorial with Application to the Exposure of Smoking. | McGuinness MB et al. | β | 2017 | β |
| The Aboriginal and Torres Strait Islander smoking epidemic: what stage are we at, and what does it mean? | Lovett R et al. | β | 2017 | β |
| The addition of tick-boxes related to tobacco cessation improves smoking-related documentation in the anaesthesia chart. | Webb A et al. | β | 2017 | β |
| The cancer risk related to meat and meat products. | Johnson IT | β | 2017 | β |
| Unravelling the associations between social isolation, loneliness, and mortality. | Liu B et al. | β | 2017 | β |
| "You've Come a Long Way, Baby": The Convergence in Age Patterns of Lung Cancer Mortality by Sex, United States, 1959-2013. | Rivadeneira NA et al. | β | 2017 | β |
| ["Do not do" also as regards tobacco]. | Olano-Espinosa E et al. | β | 2016 | β |
| Prevalence and Correlates of Smoking and Readiness to Quit Smoking in People Living with HIV in Austria and Germany. | Brath H et al. | β | 2016 | β |
| The health, financial and distributional consequences of increases in the tobacco excise tax among smokers in Lebanon. | Salti N et al. | β | 2016 | β |
| Time to raise the minimum purchasing age for tobacco in Australia. | Magnusson RS | β | 2016 | β |
| An evaluation study of a gender-specific smoking cessation program to help Hong Kong Chinese women quit smoking. | Li HC et al. | β | 2015 | β |
| A qualitative analysis of New Zealand retailers' responses to standardised packaging legislation and tobacco industry opposition. | Guthrie J et al. | β | 2015 | β |
| Cytisine is more effective than nicotine replacement for smoking cessation. | Stapleton JA | β | 2015 | β |
| Determinant factors of tobacco use among ever-married men in Bangladesh. | Rahman MS et al. | β | 2015 | β |
| Global advocacy for controlling the tobacco industry. | Beaglehole R et al. | β | 2015 | β |
| Global, regional, and national comparative risk assessment of 79 behavioural, environmental and occupational, and metabolic risks or clusters of risks in 188 countries, 1990-2013: a systematic analysis for the Global Burden of Disease Study 2013. | GBD 2013 Risk Factors Collaborators et al. | β | 2015 | β |
| [It is time to take cancer prevention seriously]. | Hill C | β | 2015 | β |
| Perceived relative harm of electronic cigarettes over time and impact on subsequent use. A survey with 1-year and 2-year follow-ups. | Brose LS et al. | β | 2015 | β |
| Seeking a comprehensive approach to tobacco control for Aboriginal and Torres Strait Islander people. | Eades SJ et al. | β | 2015 | β |
| Smoking and mortality--beyond established causes. | Nabi H et al. | β | 2015 | β |
| Smoking and mortality--beyond established causes. | Carter BD et al. | β | 2015 | β |
| Smoking-attributable cancer mortality in NSW, Australia, 1972-2008. | Creighton N et al. | β | 2015 | β |
| Smoking Prevalence and Associated Factors as well as Attitudes and Perceptions towards Tobacco Control in Northeast China. | Li Z et al. | β | 2015 | β |
| Tobacco-free generation legislation. | Walters EH et al. | β | 2015 | β |
| Traditional and Emerging Lifestyle Risk Behaviors and All-Cause Mortality in Middle-Aged and Older Adults: Evidence from a Large Population-Based Australian Cohort. | Ding D et al. | β | 2015 | β |